Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for drug evaluation, preclinical
Most Correlated Studies
- NSCLC NCI-H1299 or lung adenocarcinoma NCI-H1355 cells taxane-platin resistant with GSK-J4 or JIB-04
- Connective tissue sarcoma HT1080 cells resistant to dihydroorotate dehydrogenase inhibitor PTC299
- Acute biphenotypic leukemia MV-4-11 cells treated with JQ1 or derivative JQ1-PA
- SK-NO-1 and U-937 cells treated with tranylcypromine and all-trans-Retinoic acid
- Stage IV Triple Negative Breast Cancer treated with Cetuximab and Carboplatin
Most Relevant Literature
- Percentage of negative urine drug screens as a clinically meaningful endpoint for RCTs evaluating tr…
- Should Urine Drug Screen be Done Universally or Selectively in Palliative Care Patients on Opioids?
- A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone.
- Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confi…
- Positive Urine Drug Screens and External Mortality in Teenagers Who Present for Medical Care.
Most Relevant Clinical Trials
- MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer
- Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Pat…
- Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived …
- Patient-derived Organoids Drug Screen in Pancreatic Cancer
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
